ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2885

Erosions and Sclerosis, But Not Squaring, Predict The Development Of New Syndesmophytes: A 12-Year Longitudinal Analysis (OASIS)

Sofia Ramiro1, A.M. van Tubergen2, Désirée van der Heijde3, Carmen Stolwijk4, Maxime Dougados5, Filip Van den Bosch6 and Robert Landewé7, 1Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Department of Internal Medicine, Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 5Rheumatology B Department, Paris-Descartes University, Cochin Hospital, Paris, France, 6Ghent University Hospital, Ghent, Belgium, 7Academic Medical Center Amsterdam & Atrium Medical Center, Heerlen, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), Outcome measures, radiography and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: Imaging in Axial Spondylarthropathies: Challenges, Advances

Session Type: Abstract Submissions (ACR)

Background/Purpose: Erosions, sclerosis and squaring are included in the modified Stoke Ankylosing Spondylitis (AS) Spine Score (mSASSS). However, their value in predicting the development of new syndesmophytes has not been established, and their value in the mSASSS has been argued. We aimed at analysing the effect of erosions, sclerosis and squaring on the development of new syndesmophytes over 12 years.

Methods: Biannual radiographs from patients with AS (mNY criteria) followed in OASIS (up to 12 years) were included. Two readers (R1 and R2) independently scored the x-rays according to the mSASSS and separately registered all the items with a score of 1 (erosions, sclerosis and squaring, or any combination) per vertebral corner (VC). The progression from erosions, sclerosis and squaring to new (bridging) syndesmophytes (either score of 2 or 3 in the mSASSS) in a 2-year period and over the 12 years was investigated by means of a multilevel (adjusted for time, reader and cervical/lumbar spinal region) auto-regressive and time-lagged longitudinal model, using generalized estimating equations. Interactions with reader and spinal region were investigated.

Results: 211 patients were included in this analysis (mean age 43 (SD 13) years old, 71% male, 85% HLA-B27 positive, 11.5 (SD 9.1) years since diagnosis and 20.5 (SD 11.6) years since symptom onset, 4.4 (SD 1.8) radiographs per patient). A total of 921 radiographs were included in this analysis, with a total of 20509 VCs (R1) and 20568 VCs (R2) evaluable.  Of these, erosions were scored in 1% for R1 (2.5% R2), sclerosis in 0.3% for R1 (1.7% R2), squaring in 6.5% for R1 (5.1% R2) and syndesmophytes in 25% for R1 (27% R2). The presence of erosions, sclerosis and squaring together had, compared with a normal VC, a risk for the development of new syndesmophytes over a 2-year period of 2.0 (Table). There was a significant interaction with ‘spinal region’ (OR cervical spine: 3.1; OR lumbar spine: 1.3). There was no significant difference between the readers. Separately, the presence of erosions or the presence of sclerosis, but not the presence of squaring, gave an increased risk for new syndesmophytes, Squaring was predictive of the development of new syndesmophytes in the cervical spine only (Table).

Conclusion: Erosions and sclerosis occur rarely on X-rays, but if so, are predictive for the development of new syndesmophytes. Therefore, these lesions not only seem to precede the development of syndesmophytes, but are also correctly included in the mSASSS. The possibility of excluding squaring from the mSASSS in the lumbar spine may be considered.

Table – Longitudinal effect (GEE) of erosions, sclerosis and squaring on the development of new syndesmophytes over 12 years (adjusted for spinal region and reader)

 

 

Multivariable GEE models with syndesmphytes as the outcome*

OR (95% CI)

Same model, but with results stratified for spinal region or reader if significant interactions

OR (95% CI)

 

Factor: Erosion, sclerosis and/or squaring (score of 1 in mSASSS)

2.0 (1. 7 – 2.3)

 

Stratification

   – Cervical spine

 

3.1 (2.5 – 3.9)

   – Lumbar spine

1.3 (1.0 – 1.6)

   – Reader 1

No significant interaction

   – Reader 2

 

Factor: Erosions

2.1 (1.6 – 2.8)

 

Stratification

   – Cervical spine

 

No significant interaction

   – Lumbar spine

   – Reader 1

No significant interaction

   – Reader 2

 

Factor: Sclerosis

5.1 (3.9 – 6.8)

 

Stratification

   – Cervical spine

 

No significant interaction

   – Lumbar spine

   – Reader 1

15.3 (9.2 – 25.5)

   – Reader 2

3.9 (2.8 – 5.5)

 

Factor: Squaring

1.3 (1.0 – 1.6)

 

Stratification

   – Cervical spine

 

8.5 (2.1 – 34.7)

   – Lumbar spine

1.1 (0.8 – 1.4)

   – Reader 1

1.6 (1.2 – 2.1)

   – Reader 2

1.0 (0.6 – 1.4)

* Adjusted for spinal region and reader (each row reflects the OR for main predictor of the model, all different models).


Disclosure:

S. Ramiro,
None;

A. M. van Tubergen,
None;

D. van der Heijde,
None;

C. Stolwijk,
None;

M. Dougados,
None;

F. Van den Bosch,
None;

R. Landewé,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/erosions-and-sclerosis-but-not-squaring-predict-the-development-of-new-syndesmophytes-a-12-year-longitudinal-analysis-oasis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology